Literature DB >> 20723555

A novel approach for in vivo screening of toxins using the Drosophila Giant Fiber circuit.

Monica Mejia1, Mari D Heghinian, Alexandra Busch, Chris J Armishaw, Frank Marí, Tanja A Godenschwege.   

Abstract

Finding compounds that affect neuronal or muscular function is of great interest as potential therapeutic agents for a variety of neurological disorders. Alternative applications for these compounds include their use as molecular probes as well as insecticides. We have developed a bioassay that requires small amounts of compounds and allows for unbiased screening of biological activity in vivo. For this, we paired administering compounds in a non-invasive manner with simultaneous electrophysiological recordings from a well-characterized neuronal circuit, the Giant Fiber System of Drosophila melanogaster, which mediates the escape response of the fly. The circuit encompasses a variety of neurons with cholinergic, glutamatergic, and electrical synapses as well as neuromuscular junctions. Electrophysiological recordings from this system allow for the detection of compound-related effects against any molecular target on these components. Here, we provide evidence that this novel bioassay works with small molecules such as the cholinergic receptor blocker mecamylamine hydrochloride and the potassium channel blocker tetraethylammonium hydroxide, as well as with venom from Conus brunneus and isolated conopeptides. Conopeptides have been developed into powerful drugs, such as the painkillers Prialt™ and Xen2174. However, most conopeptides have yet to be characterized, revealing the need for a rapid and straightforward screening method. Our findings show that mecamylamine hydrochloride, as well as the α-conotoxin ImI, which is known to be an antagonist of the human α7 nicotinic acetylcholine receptor, efficiently disrupted the synaptic transmission of a Drosophila α7 nicotinic acetylcholine receptor-dependent pathway in our circuit but did not affect the function of neurons with other types of synapses. This demonstrates that our bioassay is a valid tool for screening for compounds relevant to human health. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723555      PMCID: PMC2967628          DOI: 10.1016/j.toxicon.2010.08.005

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  64 in total

Review 1.  Effects of Conus peptides on the behavior of mice.

Authors:  B M Olivera; L J Cruz; D Yoshikami
Journal:  Curr Opin Neurobiol       Date:  1999-12       Impact factor: 6.627

2.  Ion channels and synaptic organization: analysis of the Drosophila genome.

Authors:  J T Littleton; B Ganetzky
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

3.  Targeted expression of truncated glued disrupts giant fiber synapse formation in Drosophila.

Authors:  M J Allen; X Shan; P Caruccio; S J Froggett; K G Moffat; R K Murphey
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

4.  A ubiquitous family of putative gap junction molecules.

Authors:  Y Panchin; I Kelmanson; M Matz; K Lukyanov; N Usman; S Lukyanov
Journal:  Curr Biol       Date:  2000-06-29       Impact factor: 10.834

Review 5.  The voltage-gated potassium channels and their relatives.

Authors:  Gary Yellen
Journal:  Nature       Date:  2002-09-05       Impact factor: 49.962

Review 6.  Conotoxins as selective inhibitors of neuronal ion channels, receptors and transporters.

Authors:  Richard J Lewis
Journal:  IUBMB Life       Date:  2004-02       Impact factor: 3.885

7.  Electrophysiological recordings from the Drosophila giant fiber system (GFS).

Authors:  Marcus J Allen; Tanja A Godenschwege
Journal:  Cold Spring Harb Protoc       Date:  2010-07-01

Review 8.  Conotoxins - new vistas for peptide therapeutics.

Authors:  R M Jones; G Bulaj
Journal:  Curr Pharm Des       Date:  2000-08       Impact factor: 3.116

9.  Conservation of the ligand recognition site of metabotropic glutamate receptors during evolution.

Authors:  M L Parmentier; T Galvez; F Acher; B Peyre; R Pellicciari; Y Grau; J Bockaert; J P Pin
Journal:  Neuropharmacology       Date:  2000-04-27       Impact factor: 5.250

10.  Novel putative nicotinic acetylcholine receptor subunit genes, Dalpha5, Dalpha6 and Dalpha7, in Drosophila melanogaster identify a new and highly conserved target of adenosine deaminase acting on RNA-mediated A-to-I pre-mRNA editing.

Authors:  M Grauso; R A Reenan; E Culetto; D B Sattelle
Journal:  Genetics       Date:  2002-04       Impact factor: 4.562

View more
  4 in total

1.  Paired nanoinjection and electrophysiology assay to screen for bioactivity of compounds using the Drosophila melanogaster giant fiber system.

Authors:  Monica Mejia; Mari D Heghinian; Alexandra Busch; Frank Marí; Tanja A Godenschwege
Journal:  J Vis Exp       Date:  2012-04-15       Impact factor: 1.355

2.  Inhibition of cholinergic pathways in Drosophila melanogaster by α-conotoxins.

Authors:  Mari D Heghinian; Monica Mejia; David J Adams; Tanja A Godenschwege; Frank Marí
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

3.  Modern venomics-Current insights, novel methods, and future perspectives in biological and applied animal venom research.

Authors:  Bjoern M von Reumont; Gregor Anderluh; Agostinho Antunes; Naira Ayvazyan; Dimitris Beis; Figen Caliskan; Ana Crnković; Maik Damm; Sebastien Dutertre; Lars Ellgaard; Goran Gajski; Hannah German; Beata Halassy; Benjamin-Florian Hempel; Tim Hucho; Nasit Igci; Maria P Ikonomopoulou; Izhar Karbat; Maria I Klapa; Ivan Koludarov; Jeroen Kool; Tim Lüddecke; Riadh Ben Mansour; Maria Vittoria Modica; Yehu Moran; Ayse Nalbantsoy; María Eugenia Pachón Ibáñez; Alexios Panagiotopoulos; Eitan Reuveny; Javier Sánchez Céspedes; Andy Sombke; Joachim M Surm; Eivind A B Undheim; Aida Verdes; Giulia Zancolli
Journal:  Gigascience       Date:  2022-05-18       Impact factor: 7.658

4.  New tools for targeted disruption of cholinergic synaptic transmission in Drosophila melanogaster.

Authors:  Monica Mejia; Mari D Heghinian; Frank Marí; Tanja A Godenschwege
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.